Evidence map›Paper›PMID 25759243›Full record

ArticleToxicology and applied pharmacology2015

Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction.

Veronica L Massey, Kendall S Stocke, Robin H Schmidt, Min Tan, Nadim Ajami, Rachel E Neal, Joseph F Petrosino, Shirish Barve, Gavin E Arteel

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Medicinal Plant PairFrontiers in pharmacology · 2019
    Article
  5. Review
  6. Article
  7. Article
  8. Hepatic transcriptomic responses in mice exposed to arsenic and different fat diet.Environmental science and pollution research international · 2017
    Article
  9. High-Fat Diet, Dysbiosis, and Gastrointestinal and Colonic Transit: Is There a Missing Link?Cellular and molecular gastroenterology and hepatology · 2016
    Article
  10. Article
  11. Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.Drug metabolism and disposition: the biological fate of chemicals · 2015
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Veronica L MasseyDepartment of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Kendall S StockeDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Robin H SchmidtDepartment of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Min TanDepartment of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Nadim AjamiDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX, USA.
Rachel E NealDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Joseph F PetrosinoDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX, USA.
Shirish BarveDepartment of Medicine, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Gavin E ArteelDepartment of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA. Electronic address: gavin.arteel@louisville.edu.
University of Louisville · USBaylor College of Medicine · US

Funding

UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Priming of liver disease by arsenic exposureR21ES016367 · NIEHS · UNIVERSITY OF LOUISVILLE · PI ARTEEL, GAVIN E · 2009 to 2010
$406k
NIEHS NIH HHS ES011564NIEHS NIH HHS ES016367NIEHS NIH HHS R21 ES016367NIEHS NIH HHS T32 ES011564
6 · The paper itself

Abstract

Arsenic (As) tops the ATSDR list of hazardous environmental chemicals and is known to cause liver injury. Although the concentrations of As found in the US water supply are generally too low to directly damage the liver, subhepatotoxic doses of As sensitize the liver to experimental NAFLD. It is now suspected that GI microbiome dysbiosis plays an important role in development of NALFD. Importantly, arsenic has also been shown to alter the microbiome. The purpose of the current study was to test the hypothesis that the prebiotic oligofructose (OFC) protects against enhanced liver injury caused by As in experimental NAFLD. Male C57Bl6/J mice were fed low fat diet (LFD), high fat diet (HFD), or HFD containing oligofructose (OFC) during concomitant exposure to either tap water or As-containing water (4.9ppm as sodium arsenite) for 10weeks. HFD significantly increased body mass and caused fatty liver injury, as characterized by an increased liver weight-to-body weight ratio, histologic changes and transaminases. As observed previously, As enhanced HFD-induced liver damage, which was characterized by enhanced inflammation. OFC supplementation protected against the enhanced liver damage caused by As in the presence of HFD. Interestingly, arsenic, HFD and OFC all caused unique changes to the gut flora. These data support previous findings that low concentrations of As enhance liver damage caused by high fat diet. Furthermore, these results indicate that these effects of arsenic may be mediated, at least in part, by GI tract dysbiosis and that prebiotic supplementation may confer significant protective effects.

Indexed as

ArsenitesPrebioticsSodium CompoundsAlanine TransaminaseAnimalsAspartate AminotransferasesChemical and Drug Induced Liver InjuryCytoprotectionDiet, High-FatDisease Models, AnimalDysbiosisInflammation MediatorsIntestinesLiverMaleMice, Inbred C57BLAlanine TransaminaseArsenitesAspartate AminotransferasesInflammation MediatorsoligofructoseOligosaccharidesPrebioticssodium arseniteSodium CompoundsGut:liver axisLiver injuryMetagenomics

Identifiers

PMID25759243
PMCPMC4515777
OpenAlexW2078316389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.